Publication of audited financial results for the quarter and financial year ended March 31, 2026.
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fermenta Biotech Ltd has published its audited financial results for FY2025-26. Consolidated total income grew 13.8% to Rs. 54,781.46 Lakhs from Rs. 48,129.58 Lakhs, while standalone income rose 7.2% to Rs. 47,415.16 Lakhs. However, net profit after tax declined on both bases - consolidated by 8% to Rs. 7,025.43 Lakhs and standalone by 4.9% to Rs. 6,428.36 Lakhs. EPS (after exceptional items) stood at Rs. 24.70 basic per share versus Rs. 26.35 in the prior year. The Board has proposed a dividend of 75% (Rs. 3.75 per share) subject to shareholder approval. Exceptional items of Rs. 907.14 Lakhs were recorded during the year.
Revenue growth was achieved but profitability declined year-on-year. The dividend proposal signals continued shareholder returns despite lower earnings. The stock may see mixed reaction given the profit decline despite revenue expansion.